EGFR aptamer–coupled EGFR-SNPs were designed to efficiently deliver SaL, enhancing OS cytotoxicity, inhibiting tumor sphere formation, and reducing the proportion of CD133 + OS stem cells (OSCs) [135]. The gene discussed is PROM1; the disease is neoplasm.